Public Relations


"Starting with our proprietary positioning and messaging methodology – LHS Immersion® – we partner with clients to develop integrated communications’ programs that build influence and awareness and reach the right stakeholders, with the right messages at the right time."

--Sharon Correia

Our Public Relations services help our clients educate target audiences about their unique value proposition through corporate and product story development. We build influence and awareness to position our clients and/or their products as the right choice for critical stakeholders.
We provide:

Douglas Russell

Senior Vice President & General Manager

Phone: 617-374-8800 x108
Email: drussell@lavoiehealthscience.com

Sharon Correia

Vice President, Integrated Communications

Phone: 617-374-8800 x105
Email: scorreia@lavoiehealthscience.com

Bell Ringer Merit Award 2016

PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations. The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

@LaVoieGroup

- 20 hours ago

Check out this week’s @PRCouncil SheQuality podcast “Woke at Work” featuring LHS CEO @dlavoie02 Listen in for comme… https://t.co/yH2ECw4SFm
@LaVoieGroup

- 1 day ago

RT @NLNKGenetics: Congratulations to our partner @Merck, who announced the start of its rolling BLA submission to the @US_FDA for V920, a v…
@LaVoieGroup

- 1 day ago

The 60th Annual Meeting of the American Society of Hematology is two weeks away. Getting ready for opportunities to… https://t.co/krLWH7un6N
@LaVoieGroup

- 2 days ago

RT @odwyerpr: Accounts in transit: @LaVoieGroup adds Emmaus Life Sciences... @DEGdigital grabs Provista... @randjsc picks up Alfred Sanzari…

Example of Public Relations: Panel Development

PAIN: a Conversation brought together industry leaders to participate in a discussion about opioid addition and the need for alternatives. This panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals.